Linking olfactory deficits to memory impairment and AD neurodegeneration
Linking olfactory deficits to memory impairment and AD neurodegeneration
批准号:
10627943
负责人:
Prasanna Rasika Karunanayaka
金额:
$79.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-15 至 2026-04-30
关键词:
AffectAgeAgingAlzheimer associated neurodegenerationAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer’s disease biomarkerAmyloidAreaBehavioralBrainBrain regionCognitionCognitiveDataDementiaDetectionDevelopmentDiscriminationDiseaseDisease MarkerDisease ProgressionFoundationsFunctional ImagingFunctional Magnetic Resonance ImagingFunctional disorderGoalsHippocampusImpaired cognitionImpairmentInferiorInsula of ReilJointsKnowledgeLeadLinkLiteratureLobeMagnetic Resonance ImagingMedialMemoryMemory impairmentModelingNational Institute on Alcohol Abuse and AlcoholismNerve DegenerationOdorsOlfactory CortexOlfactory dysfunctionOutcomes ResearchParkinson DiseaseParticipantPathologyPathway interactionsPatternPerformancePositron-Emission TomographyPreventionProcessResearchRestSignal TransductionSmell PerceptionSpecific qualifier valueStructureTemporal LobeTestingVisualage relatedamnestic mild cognitive impairmentbiomarker evaluationclinical practicecognitive functiondesigndiagnostic toolentorhinal cortexexperimental studyimaging biomarkerimprovedin vivomemory processmild cognitive impairmentnetwork dysfunctionneuropathologynormal agingpiriform cortexpotential biomarkerpre-clinicalpredictive markerpredictive modelingprodromal Alzheimer&aposs diseaseprogressive neurodegenerationrisk predictionscreeningstructural imaging
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Olfactory impairment may signal prodromal Alzheimer’s disease (AD). We currently do not have an established
model that can be tested, in vivo, relating AD neurodegeneration to specific functional deficits in olfaction and
memory. This significant knowledge gap impedes the development of functional imaging markers for the
evaluation and diagnosis of AD.
We have developed several olfactory fMRI paradigms that can probe the dysfunctions in brain regions where
early stage AD neurodegeneration occurs. Our preliminary data suggest an AD neurodegeneration-to-function
model. We hypothesize that progressive neurodegeneration in MCI disrupts the connectivity of the olfactory
network (ON) to the default mode network (DMN) via the Hippocampus, leading to early deficits in olfaction
followed by memory impairment. Our research is designed to test this hypothesized model using functional
connectivity (FC; synchrony among brain regions) in resting state fMRI and effective connectivity (EC; directed
interactions between brain regions) during olfactory task fMRI; neurodegeneration will be evaluated by volumetric
MRI (vMRI).
Aim 1: Determine age-related changes in the ON-DMN network in cognitively normal subjects.
Aim 2: Determine changes in the ON-DMN network in mild cognitively impaired (MCI) subjects.
Aim 3: Explore the relationships between progressive changes in the ON-DMN network, and cognitive
decline in MCI subjects
The over-arching goal of the proposed research will be to rigorously test an AD neurodegeneration model that
answers two fundamental questions: a) How are odor-identification and odor-discrimination deficits in AD related
to memory impairment and neurodegeneration? and b) Do olfactory deficits and progressive disruptions to ON-
DMN connectivity signal the development of AD dementia? Research outcomes can provide numerous avenues
for improving olfactory testing as an AD marker. Olfactory tests, which target specific brain areas and processes
that are affected earliest in AD, could hold additional promise for early disease detection and prevention in other
neurodegerative disease, such as Parkinson’s disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.25259/jcis_135_2022
发表时间:
2023
期刊:
Journal of clinical imaging science
影响因子:
0.9
作者:
[]
通讯作者:
Linking olfactory deficits to memory impairment and AD neurodegeneration
-
批准号:10460576
-
项目类别:
-
资助金额:$79.86万
-
财政年份:2021
-
负责人:Prasanna Rasika Karunanayaka
-
依托单位:
Linking olfactory deficits to memory impairment and AD neurodegeneration
-
批准号:10297048
-
项目类别:
-
资助金额:$79.16万
-
财政年份:2021
-
负责人:Prasanna Rasika Karunanayaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: